What is the economic pressure of IVF in China?
As an assisted reproductive technology, IVF technology has brought good news to those couples who cannot conceive naturally. However, the accompanying high costs make many families unbearable. This article will discuss the economic pressure of IVF in China from four aspects: treatment costs, drug costs, follow-up costs and existing preferential policies.
Treatment expenses
The cost of IVF treatment in China is generally priced by the hospital according to the specific situation, which usually includes initial diagnosis fee, operation fee, embryo transfer fee, etc. According to the pricing standards of different regions and hospitals, the cost of IVF treatment is generally more than 100000 yuan, which makes many families flinch from the high cost. In addition, due to the complexity of IVF technology and the uncertainty of the success rate, some families may need to try many times, further increasing the economic burden.
However, this does not mean that IVF can only be the patent of the rich. In order to help more families in need, some large public hospitals and maternal and child health centers have set up relevant charity funds to provide subsidies for IVF treatment. In addition, some hospitals and medical insurance policies also provide partial reimbursement or payment policies to help families reduce economic pressure.
Drug expenses
In the process of IVF treatment, most couples need to use ovulation promoting drugs and hormone drugs to help ovarian ovulation and regulate endometrium, so as to improve the success rate of pregnancy. These drugs are expensive and sometimes require long-term use. According to the types and usage of different drugs, drug costs can range from several thousand yuan to ten thousand yuan.
Although drug costs are a part of IVF treatment, they also bring great pressure to families. In order to reduce the family's financial burden, some hospitals will choose to cooperate with pharmaceutical factories to provide patients with certain preferential prices. In addition, some insurance companies have begun to gradually include IVF drug reimbursement, which is a blessing for families who buy drugs.
Follow up expenses
After the success of IVF, pregnancy monitoring, embryo cryopreservation, as well as infant pregnancy, delivery and other follow-up processes are also required. The cost of these processes is also a considerable burden. For example, during the pregnancy monitoring period, it is necessary to carry out regular pregnancy examinations, pregnant women supplement nutrition, etc. These costs may add up to a considerable amount. In addition, embryo cryopreservation and infant pregnancy and delivery also cost some money.
In order to reduce the economic pressure of follow-up costs, some hospitals have launched package services, including pregnancy monitoring, embryo cryopreservation, delivery and other full services, to provide patients with more reasonable prices. Families can choose appropriate packages according to their own actual conditions to reduce their financial burden.
favoured policy
In order to help more families in need achieve their reproductive aspirations, some local governments have introduced preferential policies for IVF. For example, family planning policies in some cities exempt couples with IVF from fines; Some local governments have set up relevant special funds to provide financial assistance for IVF families; In some places, certain subsidies are provided for the reimbursement of IVF treatment expenses.
However, there are still some problems in the implementation of IVF preferential policies. Some policies have restrictions, and some families cannot enjoy substantive preferences. Therefore, under the cooperation of the government and the hospital, it is an important topic to further improve the preferential policies for IVF and reduce the economic pressure of families.
Summary
The economic pressure of domestic IVF is mainly reflected in the treatment costs, drug costs, follow-up costs and preferential policies. Although IVF technology has brought good news to families unable to conceive naturally, the high cost is still an unbearable burden for many families. However, some hospitals and governments have introduced relevant policies and preferential measures to try to reduce the economic pressure on families. In the future, the coverage and implementation of preferential policies should be further improved to provide support and help for more families in need.
